Filing Details

Accession Number:
0001179110-18-002536
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-21 19:23:17
Reporting Period:
2018-02-16
Accepted Time:
2018-02-21 19:23:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1327700 R Stephen Fussell 100 Abbott Park Road
Abbott Park IL 60064-6400
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2018-02-16 44,909 $0.00 184,884 No 4 A Direct
Common Shares Without Par Value Acquisiton 2018-02-20 104,642 $38.40 289,526 No 4 M Direct
Common Shares Without Par Value Disposition 2018-02-20 1,100 $59.47 288,426 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 300 $59.48 288,126 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 1,419 $59.49 286,707 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 441 $59.50 286,266 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 1,200 $59.50 285,066 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 1,172 $59.51 283,894 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 200 $59.52 283,694 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 728 $59.52 282,966 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 989 $59.53 281,977 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 226 $59.54 281,751 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 574 $59.55 281,177 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 180 $59.56 280,997 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 500 $59.58 280,497 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 500 $59.59 279,997 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 500 $59.59 279,497 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 100 $59.60 279,397 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 22,500 $59.60 256,897 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 1,600 $59.63 255,297 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 500 $59.64 254,797 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 1,700 $59.64 253,097 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 600 $59.65 252,497 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 4,794 $59.65 247,703 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 3,200 $59.66 244,503 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 10 $59.66 244,493 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 8,206 $59.66 236,287 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 2,985 $59.67 233,302 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 77 $59.67 233,225 No 4 S Direct
Common Shares Without Par Value Disposition 2018-02-20 100 $59.67 233,125 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Acquisiton 2018-02-16 246,963 $0.00 246,963 $59.94
Common Shares Option (right to buy) Disposition 2018-02-20 104,642 $0.00 104,642 $38.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
246,963 2019-02-16 2028-02-15 No 4 A Direct
104,642 2018-02-19 2026-02-18 No 4 M Direct
Footnotes
  1. These shares represent performance vested restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
  2. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 82,321 on 02/16/2019, 82,321 on 02/16/2020, and 82,321 on 02/16/2021.
  3. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.